Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v8-FR
Language French French
Date Updated 2018-08-23 2018-08-23
Drug Identification Number 02243098 02243098
Brand name ACETYLCYSTEINE SOLUTION ACETYLCYSTEINE SOLUTION
Common or Proper name ACETYLCYSTEINE ACETYLCYSTEINE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients ACETYLCYSTEINE ACETYLCYSTEINE
Strength(s) 200MG 200MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INHALATION INTRAVENOUS ORAL INHALATION INTRAVENOUS ORAL
Packaging size 10ML VIAL 10ML VIAL
ATC code R05CB R05CB
ATC description EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR. EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-06-23 2018-06-23
Estimated end date 2018-08-20 2018-08-20
Actual end date 2018-08-17 2018-08-17
Shortage status Resolved Resolved
Company comments
Health Canada comments